We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHX
1626
DELISTED
ChampionX
CHX
$318K ﹤0.01%
20,794
-41,244
-66% -$458K
SPIR icon
1627
Spire Global
SPIR
$432M
$317K ﹤0.01%
+3,953
New +$312K
KLRS
1628
Kalaris Therapeutics
KLRS
$85.2M
$316K ﹤0.01%
358
-694
-66% -$534K
EIDX
1629
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$316K ﹤0.01%
+2,403
New +$212K
AXDX
1630
DELISTED
Accelerate Diagnostics
AXDX
$314K ﹤0.01%
+4,136
New +$370K
AXLA
1631
DELISTED
Axcella Health Inc. Common Stock
AXLA
$313K ﹤0.01%
2,412
LOCO icon
1632
El Pollo Loco
LOCO
$493M
$312K ﹤0.01%
17,214
-86,115
-83% -$1.45M
TDS icon
1633
Telephone and Data Systems
TDS
$3.83B
$312K ﹤0.01%
+16,819
New +$309K
XLK icon
1634
State Street Technology Select Sector SPDR ETF
XLK
$114B
$312K ﹤0.01%
4,798
-44,300
-90% -$2.7M
THR
1635
DELISTED
Thermon Group Holdings
THR
$310K ﹤0.01%
19,851
-41,140
-67% -$549K
VOXX
1636
DELISTED
VOXX International Corporation Class A
VOXX
$310K ﹤0.01%
+24,286
New +$284K
TBRG
1637
DELISTED
TruBridge
TBRG
$309K ﹤0.01%
11,544
-16,351
-59% -$462K
FDMT icon
1638
4D Molecular Therapeutics
FDMT
$543M
$308K ﹤0.01%
+7,436
New +$307K
FXY icon
1639
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
$308K ﹤0.01%
3,370
+472
+16% +$42.7K
VECO icon
1640
Veeco
VECO
$2.96B
$307K ﹤0.01%
17,687
-133,590
-88% -$2.04M
GOSS icon
1641
Gossamer Bio
GOSS
$97.5M
$306K ﹤0.01%
31,676
-6,683
-17% -$65.8K
MGNI icon
1642
Magnite
MGNI
$2.73B
$306K ﹤0.01%
+9,955
New +$151K
BW icon
1643
Babcock & Wilcox
BW
$1.4B
$305K ﹤0.01%
+86,915
New +$273K
IHF icon
1644
iShares US Healthcare Providers ETF
IHF
$1.21B
$304K ﹤0.01%
+6,475
New +$287K
NGL icon
1645
NGL Energy Partners
NGL
$1.87B
$303K ﹤0.01%
+125,926
New +$375K
LCUT icon
1646
Lifetime Brands
LCUT
$202M
$302K ﹤0.01%
+19,842
New +$249K
EFA icon
1647
PUT
iShares MSCI EAFE ETF
EFA
$76.8B
$299K ﹤0.01%
4,100
-7,700
-65% -$527K
XLB icon
1648
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$299K ﹤0.01%
8,250
+1,066
+15% +$36.5K
UFI icon
1649
UNIFI
UFI
$121M
$295K ﹤0.01%
16,638
-8,773
-35% -$136K
PACK icon
1650
Ranpak Holdings
PACK
$572M
$294K ﹤0.01%
21,872
-2,522
-10% -$27.8K

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.